Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 18112526015 |
| E-mail: | sales2@runyanpharma.com |
| QQ: | 1078036220 |
| Skype: | Chat Now! |
| Address: | Room 530, 5F, building 10, Xintiandi business center, Gongshu District, |
|
Hangzhou Runyan Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the production and research and development of nucleotide and anti-virus products. The products are mainly used in pharmaceutical intermediates, veterinary drugs, food additives and other fields. After years of exploration and efforts, it has formed antiviral agents such as Oseltamivirphosphate, Remdesivir, Molnupiravir, Nirmatrelvir and other anti-virus products.And Cabozantinib Malate, Selpercatinib, Poziotinib and Isotinic Anti-Cancer pharmaceutical intermediates, polyinosinic-polycytidylic acid sodium salt, Adenosine Cyclophosphate , Uridine 5'-monophosphate disodium salt, Adenosine Triphosphate Disodium, Adenosine 5'-monophosphate, Adenosine and other nucleotides production and operation mode of nucleotide series products.
The enterprise has a sound operating mechanism, with a central laboratory, a 100000 level purification workshop meeting GMP standards, several intelligent computer controlled batching workshops, full-automatic product packaging lines and professional transport institutions, production equipment and internationally leading production technology.
Based on the principle of "moistening the world, beaming with joy", the company is constantly exploring the original road to achieve greater progress and development. We warmly welcome and look forward to common development and progress with customers at home and abroad!
|
|
| Product Name | MF | CAS | Details |
|---|
| Sitagliptin | C16H15F6N5O | 486460-32-6 | Details |
| trans-clomifene citrate; (E)-Clomiphene citrate | C32H36ClNO8 | 7599-79-3 | Details |
| Entecavir | C12H15N5O3 | 142217-69-4 | Details |
| Valganciclovir | C14H22N6O5 | 175865-60-8 | Details |
| Tofacitinib | C16H20N6O | 477600-75-2 | Details |
| Empagliflozin Intermediate | C17H16ClIO2 | 915095-94-2 | Details |
| [1,2,4]Triazolo[1,5-a]pyridin-7-ol | C6H5N3O | 1033810-70-6 | Details |
| N'-(4-Amino-2-cyanophenyl)-N,N-dimethylformamidine | C10H12N4 | 194423-17-1 | Details |
| Palmitoylethanolamide | C18H37NO2 | 544-31-0 | Details |
| Thymoquinone | C10H12O2 | 490-91-5 | Details |
| Mirabegron | C21H24N4O2S | 223673-61-8 | Details |
| Erlotinib hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
| MYK-461 (SAR-439152) | C15H19N3O2 | 1642288-47-8 | Details |
| Vardenafil;Fardenafil | C23H32N6O4S | 224785-90-4 | Details |
| Tucatinib | C26H24N8O2 | 937263-43-9 | Details |
| Selpercatinib; Loxo-292 | C29H31N7O3 | 2152628-33-4 | Details |
| Vitamin D2; Secoergosta-5,7,10(19),22-tetraen-3-ol, (3beta,5Z,7E,22E)- | C28H44O | 50-14-6 | Details |
| Maropitant Citrate | C38H48N2O8 | 359875-09-5 | Details |
| Repaglinide | C27H36N2O4 | 135062-02-1 | Details |
| Silodosin | C25H32F3N3O4 | 160970-54-7 | Details |
| Ectoine | C6H10N2O2 | 96702-03-3 | Details |
| [1,2,4]Triazolo[1,5-a]pyridine, 7-(2-methyl-4-nitrophenoxy)- | C13H10N4O3 | 937263-44-0 | Details |
| (1R,3R)- methyl -1,2,3,4-tetrahydro-1-(3,4- methylenedioxyphenyl)-9H-pyrido [3,4-B]indole-3-carboxylate | C22H19ClN2O5 | 171489-59-1 | Details |
| DZD9008;Sunvozertinib | C29H35ClFN7O3 | 2370013-49-1 | Details |
| Alprostadil;Prostaglandin E1 | C20H34O5 | 745-65-3 | Details |
| AZD-5438;AZD5438 | C18H21N5O2S | 602306-29-6 | Details |
| Ganciclovir | C9H13N5O4 | 82410-32-0 | Details |
| GSK-461364;GSK461364 | C27H28F3N5O2S | 929095-18-1 | Details |
| Afatinib | C24H25ClFN5O3 | 850140-72-6 | Details |
| Adenosine 5'-diphosphate dipotassium salt; ADP-K2; 5'-ADP-K2 | C10H16KN5O10P2 | 114702-55-5 | Details |
| Guanosine 5'-monophosphate disodium salt | C10H15N5NaO8P | 5550-12-9 | Details |
| β-Nicotinamide Mononucleotide | C11H15N2O8P | 1094-61-7 | Details |
| 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline | C13H12N4O | 937263-71-3 | Details |
| Ceftiofur sodium | C19H18N5NaO7S3 | 104010-37-9 | Details |
| TAS6417;Zipalertinib;CLN-081 | C23H20N6O | 1661854-97-2 | Details |
| Uridine 5'-triphosphate disodium salt,UTP,UTP-Na2; 5'-UTP-Na2 | C9H13N2O15P3.2Na | 285978-18-9 | Details |
| AB-106;Taletrectinib | C29H34FN5O5 | 1505515-69-4 | Details |
| BDTX-189; Tuxobertinib | C29H29ClN6O4 | 2414572-47-5 | Details |
| Pramipexole hydrochloride | C10H20ClN3OS | 191217-81-9 | Details |
| Dapoxetine hydrochloride | C21H24ClNO | 129938-20-1 | Details |
| (1R,3R)-METHYL-1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE | C20H18N2O4 | 171596-41-1 | Details |
| Favipiravir | C5H4FN3O2 | 259793-96-9 | Details |
| Ibuprofen Piconol | C19H23NO2 | 112017-99-9 | Details |
| (4R)-6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine | C6H13N5 | 775351-65-0 | Details |
| Eldecalcitol | C30H50O5 | 104121-92-8 | Details |
| Vildagliptin | C17H25N3O2 | 274901-16-5 | Details |
| 5’-Adenosine monophosphate disodium salt;AMP;AMP-Na,5-AMP-Na | C10H15N5NaO7P | 4578-31-8 | Details |
| Polyinosinic acid sodium salt，Poly I, POLY I-Na | C10H13N4O8P | 30918-54-8 | Details |
| Cevimeline HCl; Cevimeline;AF102B | C10H18ClNOS | 107220-28-0 | Details |
| Spermidine trihydrochloride | C7H22Cl3N3 | 334-50-9 | Details |
| Nintedanib | C31H33N5O4 | 656247-17-5 | Details |
| Cabozantinib | C28H24FN3O5 | 849217-68-1 | Details |
| Guanosine-5’-triphosphate disodium salt；GTP; GTP-Na2； 5‘-GTP-Na2 | C10H17N5NaO14P3 | 56001-37-7 | Details |
| AFOXOLANER; Afoxolaner fandachem | C26H17ClF9N3O3 | 1093861-60-9 | Details |
| Polycytidylic acid potassium salt，Poly C, Poly C-K | C9H13KN3O8P | 26936-40-3 | Details |
| Cytidine 5’-diphosphate trisodium salt; CDP-Na3；5-CDP-Na3 | C9H16N3NaO11P2 | 34393-59-4 | Details |
| TAK788;Mobocertinib | C32H39N7O4 | 1847461-43-1 | Details |
| Adenosine 5'-diphosphate monosodium salt;AMP-Na;5'-AMP-Na | C10H16N5NaO10P2 | 20398-34-9 | Details |
| TAK-788 succinate; AP32788 succinate;Mobocertinib succinate | C36H45N7O8 | 2389149-74-8 | Details |
| Polyinosinic–polycytidylic acid potassium salt; Poly(I:C); Poly(I:C) K | C19H27KN7O16P2* | 31852-29-6 | Details |
| Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
| Larazotide | C32H55N9O10 | 258818-34-7 | Details |
| Ko 143 | C26H35N3O5 | 461054-93-3 | Details |
| Bucladesine sodium salt；dc2797 , sodium dibutyryl camp , dibutyryl-camp sodium salt , dbcamp | C18H25N5NaO8P | 16980-89-5 | Details |
| Niraparib | C19H20N4O | 1038915-60-4 | Details |
| Cytidine 5'-triphosphate trisodium salt;CTP-Na3； 5‘-CTP-Na3 | C9H13N3Na3O14P3 | 93688-66-5 | Details |
| Baricitinib;LY3009104;INCB028050 | C16H17N7O2S | 1187594-09-7 | Details |
| Unifiram | C13H15FN2O3S | 272786-64-8 | Details |
| Osimertinib mesylate;AZD9291 | C29H37N7O5S | 1421373-66-1 | Details |
| Methyl isobutyrylacetate; -2,2-diMethyl-1,3-dioxane-4-Acetate | C7H12O3 | 42558-54-3 | Details |
| 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile | C9H6BrN3O | 1207836-10-9 | Details |
| Doxercalciferol | C28H44O2 | 54573-75-0 | Details |
| 2,2-Dimethyl-1,3-dioxane-4,6-dione | C6H8O4 | 2033-24-1 | Details |
| Fusidine,Fusidic acid | C31H48O6 | 6990-06-3 | Details |
| Prostaglandin E2;PGE2 | C20H32O5 | 363-24-6 | Details |
| 1-(4-((4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3-(1-hydroxy-2-methylpropan-2-y | C26H26N8O2S | 1429755-58-7 | Details |
| Molnupiravir;EIDD-2801;MK4482 | C13H19N3O7 | 2349386-89-4 | Details |
| Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
| Calcifediol | C27H46O3 | 63283-36-3 | Details |
| Adenosine 3',5'-cyclic monophosphate;Cyclic AMP; 3:5-CAMP;3',5'-CYCLIC AMP | C10H12N5O6P | 60-92-4 | Details |
| Falecalcitriol | C27H38F6O3 | 83805-11-2 | Details |
| Uridine 5'-triphosphate trisodium salt; UTP-Na3,5‘-UTP-Na3 | C9H16N2NaO15P3 | 19817-92-6 | Details |
| Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
| ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA) | C18H21N5O2 | 850649-61-5 | Details |
| Flibanserin; BIMT-17; BIMT-17-BS | C20H21F3N4O | 167933-07-5 | Details |
| 5’-Adenosine monophosphate acid;AMP | C10H14N5O7P | 61-19-8 | Details |
| Inosine 5'-diphosphate disodium salt; IDP-Na2; 5'-IDP-Na2 | C10H15N4NaO11P2 | 54735-61-4 | Details |
| Tofacitinib citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| Sorafenib tosylate | C21H16ClF3N4O3 | 284461-73-0 | Details |
| trans-CloMiphene Hydrochloride | C26H29Cl2NO | 14158-65-7 | Details |
| Sunifiram | C14H18N2O2 | 314728-85-3 | Details |
| Letermovir | C29H28F4N4O4 | 917389-32-3 | Details |
| 5a-hydroxy Laxogenin | C27H42O5 | 56786-63-1 | Details |
| Lorcaserin hydrochloride | C11H15Cl2N | 1431697-94-7 | Details |
| 5-amino-4-oxopentanoic acid | C5H12NO7P | 868074-65-1 | Details |
| Semaglutide | C187H291N45O59 | 910463-68-2 | Details |
| Cytidine 5’-diphosphate disodium salt;CDP;CDP-Na2； 5‘-CDP-Na2 | C9H16N3NaO11P2 | 54394-90-0 | Details |
| HM 781-36B | C23H22Cl3FN4O3 | 1429757-68-5 | Details |
| 5-Bromo-2-chlorobenzoic acid; 5-BROMO-2-CHLOROBENZOIC ACID FOR SYNTHES | C7H4BrClO2 | 21739-92-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 | ||||